The Teddy Bear Book is the only reference of its kind that focuses on the unique issues that healthcare professionals face when using injectable medications in children, such as limited fluid volumes, maximum concentrations, and rates of administration. The 12th Edition features more than 270 updated monographs (including over 40 monographs new to this edition) that cover the following areas: Safety issues Infusion-related cautions Dosages and conditions requiring dosage adjustments Contraindications and warnings Adverse drug effects Preparation and compatibility Bolus, intermittent, and continuous IV administration Monitoring

ASHP’s New and Expanded Guide to IV Compatibility & Stability For more than 40 years, ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug Information™ now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make informed patient care decisions. For the first time ever, this gold standard reference is available as an eBook with new and expanded information. The 2021 edition features 18 new monographs, and nearly 200 new references for a total of over 24,000 total compatibility pairs. Backed by quality, peer-reviewed published literature, and authored under the editorial authority of ASHP, ASHP® Injectable Drug Information™ is a must-have resource for every pharmacy.

Backed by quality, peer-reviewed published literature, ASHP® Injectable Drug Information™ has been one of pharmacy’s most trusted resources for more than four decades. Authored under the editorial authority of AHFS Drug Information® and published by ASHP, it is the global gold standard for IV compatibility and stability information. The 2025 Edition of the industry’s go-to guide is newly updated with the latest information, ASHP’s Standardize 4 Safety (S4S) concentration standards including new Adult and Pediatric PCA and Epidural standard concentrations, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, 25 new monographs, and more than 270 new references for a total of over 25,000 total compatibility pairs.

Everything pharmacists and pharmacy students need to know about drug information management A Doody's Core Title for 2023! Drug Information: A Guide for Pharmacists provides you with the tools you need to to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible. This trusted resource addresses essential topics such as formulating an effective response and recommendations for information, evaluation of drug literature, the application of statistical analysis in the biomedical sciences, medications and patient safety, investigational drugs, and more. This updated seventh edition also addresses other important issues such as the legal and ethical considerations of providing information, how to respond to requests for information, and how to determine what information should be made available.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

When caring for patients, medication stability should be the least of your worries. Extended Stability for Parenteral Drugs, Fifth Edition, is the indispensable go-to reference for anyone working in alternate site infusion or preparing sterile compounds. This new edition will help you safely extend beyond-use dating of parenteral medications to minimize waste and reduce costs. What''s New in This Edition? � 160 updated monographs, including 10 new to this edition: o Acetaminophen o Ceftaroline fosamil o Coagulation Factor XIII o Doripenem o Ethanol lock o Ibuprofen o Pantoprazole o Telavancin o Toclizumab o Ziconotide acetate � 24 parenteral nutrition monographs include additional considerations for calcium and phosphate solubility. � Monograph updates include revisions to several container types and new information for elastometric infusion device brands. The Applying Stability Data in Patient Care section now includes a nursing perspective, a primer on the types of vascular access devices used in medication administration, and important considerations for pH, osmolality, concentration, and administration devices. With expanded tables and enhanced references, Extended Stability for Parenteral Drugs, Fifth Edition, is the only publication that brings key stability data on the most commonly used IV solutions, medications, and administration devices, together in one convenient, easy-to-use guide.

This book provides an insight of relevant case studies and updated practices in “PharmaceuticalSupply Chains” (PharmSC) while addressing the most relevant topics within the COST Action “Medicines Shortages” (CA15105).The volume focuses on the most recent developments in the design, planning and scheduling ofPharmSC, broadening from the suppliers’ selection to the impact on patients and healthcaresystems, addressing uncertainty and risk mitigation, and computational issues. It is directed at MSc/PhD students and young researchers (Post-Docs) in Pharmaceutics/Pharmaceutical sciences, Engineering fields, Economics/Management, as well as pharmaceutical decision makers, managers, and practitioners, and advanced readers demanding a fresh approach to decision making for PharmSC. The contributed chapters are associated with the homonymous COST Training Schools (TS), and the book creates a better understanding of the Action “Medicines Shortages” challenges and opportunities.